Biochem J 2011, 434:181–188 PubMedCrossRef 6 Xing X, Lai M, Wang

Biochem J 2011, 434:181–188.Crenolanib supplier PubMedCrossRef 6. Xing X, Lai M, Wang Y: Overexpression of glucose-regulated protein 78 in colon cancer. Clin Chim Acta 2006, 364:308–315.PubMedCrossRef 7. Zhang J, Jiang Y, Jia Z: Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis 2006, 23:401–410.PubMedCrossRef 8. Gonzalez-Gronow M, Cuchacovich M, Llanos C: Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum. Cancer Res 2006, 66:11424–11431.PubMedCrossRef 9. Su R, Li Z, Li H, Song

H, Wei J, Bao C, Cheng L: Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer 2010, 10:20–32.PubMedCrossRef 10. Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Yoshimastu T, Morita M, Yasumoto K: Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance. Lung ATM Kinase Inhibitor manufacturer Cancer selleck chemicals 2005, 49:55–62.PubMedCrossRef 11. Totsukawa G, Wu Y, Sasaki Y, Hartshorne DJ, Yamakita Y, Yamashiro S, Matsumura F: Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts.

J Cell Biol 2004, 164:427–439.PubMedCrossRef 12. Sahai E: Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005, 15:87–96.PubMedCrossRef 13. Kraljevic PS, Sedic M, Bosnjak H, Spaventi S, Pavelic K: Metastasis: new perspectives on an old problem. Mol Cancer 2011, 10:22.CrossRef 14. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC: The role of focal-adhesion kinase in cancer – a new therapeutic opportunity. Nat Rev Cancer 2005, 5:505–515.PubMedCrossRef 15. Mitra SK, Hanson Cobimetinib mw DA, Schlaepfer DD: Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005, 6:56–68.PubMedCrossRef 16. Kondo S, Shukunami C, Morioka Y, Matsumoto N, Takahashi R, Oh J, Atsumi T, Umezawa A, Kudo A, Kitayama H, Hiraki Y, Noda M: Dual effects of the membrane-anchored

MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J Cell Sci 2007, 120:849–857.PubMedCrossRef 17. Zucker S, Vacirca J: Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101–117.PubMedCrossRef 18. Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM: Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 2004, 15:7621–7628.CrossRef 19. Ispanovic E, Hass TL: JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 2006, 291:C579-C588.PubMedCrossRef 20. Fromigué O, Hamidouche Z, Marie PJ: Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem 2008, 283:30549–30556.

Comments are closed.